Author:
Sterlé Marylise,Schmitt Antonin,Boulin Mathieu
Reference10 articles.
1. European Society of Cardiology (ESC) Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021
2. Clinical pharmacokinetics of digoxin;Lisalo;Clin Pharmacokinet,1977
3. European Medicines Agency. Noxafil. Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/posaconazole-accord-epar-product-information_en.pdf. Last accessed April 10, 2024.
4. European Medicines Agency. Venclyxto. Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/venclyxto-epar-product-information_en.pdf. Last accessed April 10, 2024.
5. Association of serum digoxin concentration and outcomes in patients with heart failure;Rathore;JAMA,2003